Keyphrases
Treatment Outcome
100%
Inflammatory Markers
100%
Treatment-resistant Depression
100%
Inflammatory Treatment
100%
Antidepressant Treatment
42%
Interleukin-6
42%
C-reactive Protein
28%
Predictive Value
14%
PubMed
14%
Depressed Patients
14%
Central Nervous System
14%
Exclusion Criteria
14%
Inclusion Criteria
14%
Literature Search
14%
Inflammatory Process
14%
Tumor Necrosis Factor-α
14%
Interferon-γ
14%
Treatment Response
14%
Infliximab
14%
Treatment Type
14%
Ketamine
14%
High-sensitivity C-reactive Protein (hs-CRP)
14%
Methodological Variation
14%
High CRP
14%
Medline Database
14%
Treatment Response Prediction
14%
Inflammatory Subtype
14%
Depression Biomarkers
14%
Medicine and Dentistry
Treatment Resistant Depression
100%
Systematic Review
100%
Antidepressant
42%
Interleukin 6
42%
C Reactive Protein
42%
Treatment Response
28%
Central Nervous System
14%
Tumor Necrosis Factor
14%
Drug Therapy
14%
Ketamine
14%
Anti-Inflammatory Drug
14%
Serositis
14%
Gamma Interferon
14%
Infliximab
14%
Psychology
Nervous System
100%
Medline
100%
Systematic Review
100%
Inflammatory Process
100%
Immunology and Microbiology
Interleukin 6
100%
C-Reactive Protein
100%
Medline
66%
Central Nervous System
33%
Tumor Necrosis Factor Alpha
33%
Interferon Gamma
33%
Infliximab
33%
Pharmacology, Toxicology and Pharmaceutical Science
Treatment Resistant Depression
100%
Antidepressant
42%
Interleukin 6
42%
C Reactive Protein
42%
Tumor Necrosis Factor
14%
Ketamine
14%
Inflammation
14%
Anti-Inflammatory Drug
14%
Gamma Interferon
14%
Infliximab
14%
Neuroscience
Treatment-Resistant Depression
100%
Antidepressant
42%
Interleukin 6
42%
C-Reactive Protein
42%
Central Nervous System
14%
Anti-Inflammatory
14%
Tumor Necrosis Factor Alpha
14%
Infliximab
14%
Ketamine
14%
Interferon Gamma
14%